Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
629 cases » 19 cases (Expand Search), 24 cases (Expand Search), 26 cases (Expand Search)
ad cases » all cases (Expand Search), 19 cases (Expand Search), _ cases (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
629 cases » 19 cases (Expand Search), 24 cases (Expand Search), 26 cases (Expand Search)
ad cases » all cases (Expand Search), 19 cases (Expand Search), _ cases (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
-
141
-
142
-
143
-
144
Table5_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
145
Image2_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.JPEG
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
146
Table10_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
147
Table7_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
148
Table4_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
149
Table9_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
150
Table12_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
151
Table2_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
152
Image1_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.JPEG
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
153
Table3_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
154
Table6_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
155
Table11_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
156
Table8_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
157
Table1_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLS
Published 2022“…<p>Alzheimer’s disease (AD) is a degenerative disease of central nervous system with unclear pathogenesis, accounting for 60%–70% of dementia cases. …”
-
158
-
159
-
160